Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In the clinic, GLP-2 analogs are mainly administered by subcutaneous injection, and patient compliance is poor, so this experiment chose the DPP-IV inhibitor sitagliptin to indirectly increase the level of GLP-2 by gavage in mice, and for the administration of sitagliptin, the following points are explained: Intraperitoneal injection is the injection of the drug into the animal's gastrointestinal tract outside the plasma membrane and within the peritoneum and is generally used for administration where absorption through the gastrointestinal tract is inappropriate or less efficient
Typical results vary up to 6 and 8 pounds lost during the first two weeks and up to 2 pounds per week thereafter when the Ideal Protein Weight Loss Protocol is followed properly
The actual injection
Modern routines include: A balanced 2026 routine follows simple steps
